AU5405494A - Method for preventing or treating liver disease - Google Patents

Method for preventing or treating liver disease

Info

Publication number
AU5405494A
AU5405494A AU54054/94A AU5405494A AU5405494A AU 5405494 A AU5405494 A AU 5405494A AU 54054/94 A AU54054/94 A AU 54054/94A AU 5405494 A AU5405494 A AU 5405494A AU 5405494 A AU5405494 A AU 5405494A
Authority
AU
Australia
Prior art keywords
preventing
liver disease
treating liver
treating
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54054/94A
Inventor
Ralph Schwall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU5405494A publication Critical patent/AU5405494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU54054/94A 1992-10-30 1993-10-14 Method for preventing or treating liver disease Abandoned AU5405494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96878492A 1992-10-30 1992-10-30
US968784 1992-10-30
PCT/US1993/009885 WO1994009809A1 (en) 1992-10-30 1993-10-14 Method for preventing or treating liver disease

Publications (1)

Publication Number Publication Date
AU5405494A true AU5405494A (en) 1994-05-24

Family

ID=25514774

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54054/94A Abandoned AU5405494A (en) 1992-10-30 1993-10-14 Method for preventing or treating liver disease

Country Status (2)

Country Link
AU (1) AU5405494A (en)
WO (1) WO1994009809A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR638101A0 (en) * 2001-07-13 2001-08-09 Bioa Pty Limited Composition and method for treatment of disease
WO2005032578A1 (en) 2003-10-06 2005-04-14 Monash University Therapeutic method
WO2011064309A1 (en) * 2009-11-25 2011-06-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for hepatic differentiation of definitive endoderm cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2096441A1 (en) * 1990-11-16 1992-05-17 Celtrix Pharmaceuticals, Inc. Heterodimer of b-type transforming growth factors 2 and 3
US5216126A (en) * 1991-06-19 1993-06-01 Genentech, Inc. Receptor polypeptides and their production and uses

Also Published As

Publication number Publication date
WO1994009809A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
AU2187992A (en) Composition and method for disease treatment
AU7484094A (en) Method for treating brain tumors
AU4861493A (en) Clear leave-on treatment composition and method
AU4615693A (en) Method for access control
AU1090795A (en) Method for preventing tissue injury from hypoxia
ZA939369B (en) Method of milling.
AU7254396A (en) Method for treating alcoholic liver disease
AU2719392A (en) Method for treating etchant
AU3406893A (en) Method and composition for the treatment of osteoporosis
AU1912992A (en) Method for treating hypothermia
AU6950894A (en) Composition and method for inhibiting plant disease
AU3385693A (en) Determination method
AU3975993A (en) Method and composition for treating acne
EP0722723A3 (en) Phenol derivatives for treating multiple sclerosis
AU3838793A (en) Method for preventing and treating atherosclerosis
AU1888692A (en) Composition and method for treating tumors
AU5270693A (en) Pharmaceutical composition for preventing or treating arteriosclerosis
AU4703896A (en) Method for treating multiple sclerosis
AU3473193A (en) Treatment for atherosclerosis
AU3720293A (en) Method and compositions for treating acne
AU5405494A (en) Method for preventing or treating liver disease
HU9300927D0 (en) Method for hetero-annulation
AU661596B2 (en) Veterinary method
AU5134693A (en) Method for treating psoriasis
AU4261793A (en) Wedge-welding method